Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PCSA Processa Pharmaceuticals, Inc.

休市中 08-23 16:00:00 EDT

1.45

-0.03

-2.03%

盘后1.45

+0.000.00%

19:49 EDT

最高1.52	最低1.43	成交量3.06万
今开1.49	昨收1.48	日振幅6.07%
总市值472.26万	流通市值418.48万	总股本325.69万
成交额4.50万	换手率1.06%	流通股本288.61万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PCSA","market":"US","secType":"STK","nameCN":"Processa Pharmaceuticals, Inc.","latestPrice":1.45,"timestamp":1724443200000,"preClose":1.48,"halted":0,"volume":30578,"hourTrading":{"tag":"盘后","latestPrice":1.45,"preClose":1.45,"latestTime":"19:49 EDT","volume":3,"amount":4.34,"timestamp":1724456986755},"delay":0,"floatShares":2886100,"shares":3256944,"eps":-4.985127,"marketStatus":"休市中","marketStatusCode":7,"change":-0.03,"latestTime":"08-23 16:00:00 EDT","open":1.49,"high":1.5199,"low":1.43,"amount":45015.5739368,"amplitude":0.060743,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.985127,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"adjPreClose":1.48,"preHourTrading":{"tag":"盘前","latestPrice":1.5928,"preClose":1.5,"latestTime":"09:26 EDT","volume":329,"amount":515.9761285,"timestamp":1724419596817},"postHourTrading":{"tag":"盘后","latestPrice":1.45,"preClose":1.45,"latestTime":"19:49 EDT","volume":3,"amount":4.34,"timestamp":1724456986755},"volumeRatio":0.3484651306163715},"requestUrl":"/m/hq/s/PCSA/tweets","defaultTab":"tweets","newsList":[{"id":"2460001414","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460001414","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460001414?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:32","pubTimestamp":1724160733,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日21时32分，Processa Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.92%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Inmed Pharmaceuticals Inc.、泰坦制药、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Inmed Pharmaceuticals Inc.、泰坦制药、Alzamend Neuro, Inc.较为活跃，换手率分别为1682.65%、320.23%、178.49%，振幅较大的相关个股有Inmed Pharmaceuticals Inc.、泰坦制药、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为69.26%、16.13%、8.52%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820213214ab5ea2f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820213214ab5ea2f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2460003442","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大涨8.97%报1.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460003442","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460003442?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:50","pubTimestamp":1724075410,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时50分，Processa Pharmaceuticals, Inc.股票出现异动，股价大幅拉升8.97%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921501098e355a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921501098e355a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2460242012","title":"Processa Pharmaceuticals Inc 报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2460242012","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460242012?lang=zh_cn&edition=full","pubTime":"2024-08-17 05:01","pubTimestamp":1723842118,"startTime":"0","endTime":"0","summary":"   * Processa Pharmaceuticals Inc    公布了截至 6 月份的季度调整后每股亏损 1.01 美元，高于去年同期的每股收益 40.00 美元。* 报告收入为零，分析师预期为零。* Processa Pharmaceuticals Inc 报告的本季度每股收益为亏损 1.01 美元。* 该公司当季亏损 301 万美元。* 本季度，Processa Pharmaceuticals Inc 的股价下跌了 41.5%，今年迄今为止下跌了 80.4%。8月16日 - 预测变化   * 在过去三个月中，分析师的平均盈利预期没有变化。华尔街对 Processa Pharmaceuticals Inc 的 12 个月目标价中位数为 44.00 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Processa Pharmaceuticals Inc 报告截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2459248322","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大涨5.34%报1.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459248322","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459248322?lang=zh_cn&edition=full","pubTime":"2024-08-16 22:25","pubTimestamp":1723818311,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日22时25分，Processa Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.34%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Cingulate Inc.、Geovax Labs, Inc.涨幅较大，Cingulate Inc.、Seelos Therapeutics, Inc.、Geovax Labs, Inc.较为活跃，换手率分别为4478.31%、1638.27%、355.92%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Cingulate Inc.、Geovax Labs, Inc.，振幅分别为100.53%、53.54%、51.34%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081622251198e352f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081622251198e352f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2459433793","title":"Processa Pharmaceuticals Inc    预计每股亏损 1.02 美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2459433793","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459433793?lang=zh_cn&edition=full","pubTime":"2024-08-15 04:47","pubTimestamp":1723668479,"startTime":"0","endTime":"0","summary":"   * Processa Pharmaceuticals Inc    预计在11月11日公布截至2024年9月30日的业绩报告时，季度收入将没有变化(预计)。*    * LSEG分析师对Processa Pharmaceuticals Inc的平均预期是每股亏损1.02美元。* 华尔街对 Processa Pharmaceuticals Inc 的 12 个月目标价中位数为 44.00 美元，高于上一次收盘价 1.36 美元。8月14日 - 本摘要于北京时间 8 月 14 日 20:47 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Processa Pharmaceuticals Inc    预计每股亏损 1.02 美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCSA"],"gpt_icon":0},{"id":"2459183510","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌6.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459183510","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459183510?lang=zh_cn&edition=full","pubTime":"2024-08-13 23:00","pubTimestamp":1723561232,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日23时00分，Processa Pharmaceuticals, Inc.股票出现波动，股价急速下挫6.16%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.74%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813230033aefea07e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813230033aefea07e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2458981248","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.02%报1.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458981248","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458981248?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:51","pubTimestamp":1723470677,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时51分，Processa Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.02%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.90%。其相关个股中，Revance Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.、Revance Therapeutics, Inc.较为活跃，换手率分别为74.66%、45.06%、29.66%，振幅较大的相关个股有Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.、Cingulate Inc.，振幅分别为30.36%、28.58%、23.72%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081221511896825bd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081221511896825bd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2457827705","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457827705","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457827705?lang=zh_cn&edition=full","pubTime":"2024-08-08 01:15","pubTimestamp":1723050903,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日01时15分，Processa Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.91%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.32%。其相关个股中，G1 Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Salarius Pharmaceuticals, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为5000.38%、1775.52%、326.10%，振幅较大的相关个股有Aditxt, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Salarius Pharmaceuticals, Inc.，振幅分别为101.30%、69.66%、55.91%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080801150396824d51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080801150396824d51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2457150880","title":"Processa Pharmaceuticals Inc    预计每股亏损 98 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457150880","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457150880?lang=zh_cn&edition=full","pubTime":"2024-08-07 08:27","pubTimestamp":1722990429,"startTime":"0","endTime":"0","summary":"   * 预计Processa Pharmaceuticals Inc    将于8月8日公布截至2024年6月30日的财报()。*    * LSEG分析师对Processa Pharmaceuticals Inc的平均预期是每股亏损98美分。* 目前分析师对该公司股票的平均评级为 \"买入\"，建议的细分为 2 个 \"强烈买入 \"或 \"买入\"，1 个 \"持有\"，没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Processa Pharmaceuticals Inc 的 12 个月目标价中位数为 44.00 美元，高于上一次收盘价 1.86 美元。8月7日 - 本摘要于北京时间 8 月 7 日 00:27 机器生成。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Processa Pharmaceuticals Inc    预计每股亏损 98 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCSA"],"gpt_icon":0},{"id":"2457727640","title":"Processa Pharmaceuticals, Inc.盘中异动 急速上涨6.18%报1.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457727640","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457727640?lang=zh_cn&edition=full","pubTime":"2024-08-07 02:18","pubTimestamp":1722968315,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日02时18分，Processa Pharmaceuticals, Inc.股票出现波动，股价快速拉升6.18%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为2.13%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807021835941feadd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807021835941feadd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2456072284","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456072284","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456072284?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:48","pubTimestamp":1722606522,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时48分，Processa Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.50%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.85%。其相关个股中，Exicure, Inc.、Os Therapies Incorporated、Dermata Therapeutics, Inc.涨幅较大，Dermata Therapeutics, Inc.、Exicure, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1297.01%、503.33%、41.37%，振幅较大的相关个股有Os Therapies Incorporated、Exicure, Inc.、Dermata Therapeutics, Inc.，振幅分别为54.19%、49.18%、37.50%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802214842941fd930&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802214842941fd930&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2456436563","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.51%报2.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456436563","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456436563?lang=zh_cn&edition=full","pubTime":"2024-08-01 22:02","pubTimestamp":1722520950,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日22时02分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.51%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Immuneering Corporation、Biomea Fusion, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Windtree Therapeutics, Inc.、Immuneering Corporation、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为194.37%、159.58%、72.04%，振幅较大的相关个股有Windtree Therapeutics, Inc.、Immuneering Corporation、Biomea Fusion, Inc.，振幅分别为40.35%、29.20%、27.92%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801220230aefcb6c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801220230aefcb6c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2455314001","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.26%报2.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455314001","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455314001?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:33","pubTimestamp":1722432810,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日21时33分，Processa Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.26%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731213330aefc79ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731213330aefc79ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2455309149","title":"Processa Pharmaceuticals, Inc.股价飙升66.47% 市值涨537.61万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455309149","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455309149?lang=zh_cn&edition=full","pubTime":"2024-07-30 21:31","pubTimestamp":1722346277,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日21时31分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速拉升66.47%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。其相关个股中，Imunon, Inc.、Processa Pharmaceuticals, Inc.、Pharming Group Nv涨幅较大，Cns Pharmaceuticals, Inc.、Processa Pharmaceuticals, Inc.、Imunon, Inc.较为活跃，换手率分别为739.35%、704.56%、568.86%，振幅较大的相关个股有Imunon, Inc.、Processa Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.，振幅分别为46.22%、27.06%、8.64%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730213117956d3c23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730213117956d3c23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2453064448","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453064448","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453064448?lang=zh_cn&edition=full","pubTime":"2024-07-24 03:44","pubTimestamp":1721763867,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日03时44分，Processa Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.12%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Azitra Inc、Salarius Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc涨幅较大，Salarius Pharmaceuticals, Inc.、Azitra Inc、Adial Pharmaceuticals, Inc较为活跃，换手率分别为9944.94%、7699.92%、3746.60%，振幅较大的相关个股有Azitra Inc、Salarius Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc，振幅分别为474.07%、366.13%、155.66%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407240344279681f651&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407240344279681f651&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2452167314","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.14%报1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452167314","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452167314?lang=zh_cn&edition=full","pubTime":"2024-07-18 00:27","pubTimestamp":1721233645,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日00时27分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.14%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.98%。其相关个股中，Aptevo Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃，换手率分别为3223.61%、1365.33%、291.95%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Aditxt, Inc.、4D Molecular Therapeutics, Inc.，振幅分别为76.39%、46.25%、45.71%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718002725941f7f74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718002725941f7f74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2450364610","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450364610","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450364610?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:57","pubTimestamp":1720709861,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时57分，Processa Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.26%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc、Omniab Inc C/Wts 涨幅较大，Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为590.27%、516.29%、366.23%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited，振幅分别为149.07%、88.60%、82.31%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112257429681c0c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112257429681c0c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2449670974","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘大幅下挫5.77%报1.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449670974","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449670974?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:24","pubTimestamp":1720448666,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时24分，Processa Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.77%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708222427af91183b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708222427af91183b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2449429361","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌6.08%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449429361","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449429361?lang=zh_cn&edition=full","pubTime":"2024-07-05 22:03","pubTimestamp":1720188230,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日22时03分，Processa Pharmaceuticals, Inc.股票出现波动，股价大幅跳水6.08%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Kintara Therapeutics, Inc.、Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为2301.56%、1381.34%、46.51%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Qualigen Therapeutics, Inc.、Mediwound Ltd.，振幅分别为149.83%、41.31%、33.49%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407052203509681a2b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407052203509681a2b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2448499481","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘急速跳水5.69%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448499481","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448499481?lang=zh_cn&edition=full","pubTime":"2024-07-03 22:53","pubTimestamp":1720018390,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日22时53分，Processa Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.69%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.91%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其“监管科学”方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703225311968193b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703225311968193b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.processapharmaceuticals.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.1212},{"period":"3month","weight":-0.1944},{"period":"6month","weight":-0.3409},{"period":"1year","weight":-0.7681},{"period":"ytd","weight":-0.7833}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Processa Pharmaceuticals, Inc.成立于2011年3月29日。该公司是一家临床阶段的生物制药公司，致力于药物产品的开发，该产品旨在为高度未满足的患者提供治疗方法并改善其生存率和生活质量。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.245296},{"month":2,"riseRate":0.666667,"avgChangeRate":0.111339},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.094091},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.072959},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.095736},{"month":6,"riseRate":0.714286,"avgChangeRate":0.170494},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.109157},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.099388},{"month":9,"riseRate":0.666667,"avgChangeRate":0.119026},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.111719},{"month":11,"riseRate":0.333333,"avgChangeRate":0.108897},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.158361}],"exchange":"NASDAQ","name":"Processa Pharmaceuticals, Inc.","nameEN":"Processa Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Processa Pharmaceuticals, Inc.(PCSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Processa Pharmaceuticals, Inc.,PCSA,Processa Pharmaceuticals, Inc.股票,Processa Pharmaceuticals, Inc.股票老虎,Processa Pharmaceuticals, Inc.股票老虎国际,Processa Pharmaceuticals, Inc.行情,Processa Pharmaceuticals, Inc.股票行情,Processa Pharmaceuticals, Inc.股价,Processa Pharmaceuticals, Inc.股市,Processa Pharmaceuticals, Inc.股票价格,Processa Pharmaceuticals, Inc.股票交易,Processa Pharmaceuticals, Inc.股票购买,Processa Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Processa Pharmaceuticals, Inc.(PCSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}